Litigating Civil Antitrust Matters In The United States
Select a format
This book offers both lawyer and non-lawyer the opportunity to understand the various types of civil antitrust litigation that is active in the United States. The book is organized by legal theory and starts with by addressing the most common type of antitrust litigation, which is litigation arising under Section 1 of the Sherman Act. The book then addresses Section 2 (monopolies) and the Robinson-Patman Act, before devoting two chapters to the intersection of antitrust and intellectual property, both generally and specifically with respect to the pharmaceutical industry. The book concludes by addressing issues associated with litigating civil antitrust claims brought by the federal government.
The focus is on trying to make the chapters easy to read while still providing sufficient case citations so that a lawyer who wishes to pursue a more in-depth focus on a topic would have the leading cases at his or her disposal. The book will be updated in order to account for new developments in the law.
eBooks, CDs, downloadable content, and software purchases are non-cancellable, nonrefundable and nonreturnable. Click here for more information about LexisNexis eBooks. The eBook versions of this title may feature links to Lexis+™ for further legal research options. A valid subscription to Lexis+™ is required to access this content.
Table of Contents
• Chapter 1 - Sherman Act 1 Claims
• Chapter 2 - Sherman Act 2 Claims
• Chapter 3 - The Robinson-Patman Act
• Chapter 4 - Antitrust Class Actions
• Chapter 5 - Antitrust Issues Raised by the Assertion of Intellectual Property Rights
• Chapter 6 - Pharmaceutical Antitrust: Rethinking First Principles in the Context of Hatch-Waxman
• Chapter 7 - Litigating Against the Government